References
- Wiechers JW. (2009). Nanotechnology and skin delivery: infinitely small or infinite possibilities? Cosmetics and Toiletries, 13.
- Olds WJ, McKinley AR, Moore MR, Kimlin MG. (2008). In vitro model of vitamin D3 (cholecalciferol) synthesis by UV radiation: dose-response relationships. J Photochem Photobiol B, Biol, 93:88–93.
- Kricker A, Armstrong B. (2006). Does sunlight have a beneficial influence on certain cancers? Prog Biophys Mol Biol, 92:132–139.
- Kimlin M, Harrison S, Nowak M, Moore M, Brodie A, Lang C. (2007). Does a high UV environment ensure adequate vitamin D status? J Photochem Photobiol B, Biol, 89:139–147.
- Zittermann A, Gummert JF. (2010). Sun, vitamin D, and cardiovascular disease. J Photochem Photobiol B, Biol, 101:124–129.
- Chadwick CA, Potten CS, Nikaido O, Matsunaga T, Proby C, Young AR. (1995). The detection of cyclobutane thymine dimers, (6-4) photolesions and the Dewar photoisomers in sections of UV-irradiated human skin using specific antibodies, and the demonstration of depth penetration effects. J Photochem Photobiol B, Biol, 28:163–170.
- Haake AR, Polakowska RR. (1995). UV-induced apoptosis in skin equivalents: inhibition by phorbol ester and Bcl-2 overexpression. Cell Death Differ, 2:183–193.
- Kirchhoff VWJH. (1995) Ozônio e Radiação UV-B, São José dos Campos, São Paulo. Transtec Editorial.
- Vioux-Chagnoleau C, Lejeune F, Sok J, Pierrard C, Marionnet C, Bernerd F. (2006). Reconstructed human skin: From photodamage to sunscreen photoprotection and anti-aging molecules. J Dermatol Sci Suppl, 2:S1–S12.
- Vink AA, Berg RJ, de Gruijl FR, Roza L, Baan RA. (1991). Induction, repair and accumulation of thymine dimers in the skin of UV-B-irradiated hairless mice. Carcinogenesis, 12:861–864.
- Matsumura Y, Ananthaswamy HN. (2003).Toxic effects of ultraviolet radiation on the skin. Toxicol Appl Pharmacol, 195:298–308.
- Halliday GM, Norval M, Byrne SN, Huang XX, Wolf P. (2008). The effects of sunlight on the skin. Drug Discovery Today: Disease Mechanisms, 5:201–209.
- Bernerd F, Asselineau D. (1998). UVA exposure of human skin reconstructed in vitro induces apoptosis of dermal fibroblasts: subsequent connective tissue repair and implications in photoaging. Cell Death Differ, 5:792–802.
- Tanner PR. (2006). Sunscreen product formulation. Dermatol Clin, 24:53–62.
- Flor J, Davolos MR, Correa MA. (2006). Protetores solares. Química Nova, 30:153–158.
- Schauder S, Ippen H. (1997). Contact and photocontact sensitivity to sunscreens. Review of a 15-year experience and of the literature. Contact Derm, 37:221–232.
- Lautenschlager S, Wulf HC, Pittelkow MR. (2007). Photoprotection. Lancet, 370:528–537.
- Gamer AO, Leibold E, van Ravenzwaay B. (2006). The in vitro absorption of microfine zinc oxide and titanium dioxide through porcine skin. Toxicol In Vitro, 20:301–307.
- Hany J, Nagel R. (1995). Detection of UV filter substances in breast milk. German Food Observations, 11:341–345.
- Janjua NR, Mogensen B, Andersson AM, Petersen JH, Henriksen M, Skakkebaek NE et al. (2004). Systemic absorption of the sunscreens benzophenone-3, octyl-methoxycinnamate, and 3-(4-methyl-benzylidene) camphor after whole-body topical application and reproductive hormone levels in humans. J Invest Dermatol, 123:57–61.
- Ojoe E, Luna FP, Mirabelli F. (2004). Inovação em fotoproteção. Int J Pharma Compound, 6: 317–320.
- Melquiades FL, Ferreira DD, Appoloni CR, Lopes F, Lonni AG, Oliveira FM et al. (2008). Titanium dioxide determination in sunscreen by energy dispersive X-ray fluorescence methodology. Anal Chim Acta, 613:135–143.
- Müller RH, Radtke M, Wissing SA. (2002). Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations. Adv Drug Deliv Rev, 54 Suppl 1:S131–S155.
- Wissing SA, Müller RH. (2003). Cosmetic applications for solid lipid nanoparticles (SLN). Int J Pharm, 254:65–68.
- Pardeike J, Hommoss A, Müller RH. (2009). Lipid nanoparticles (SLN, NLC) in cosmetic and pharmaceutical dermal products. Int J Pharm, 366:170–184.
- Lautenschlager H. (2006). Lipossomes. Handbook of cosmetic science and technology, CRC Press Taylor & Francis Group, Boca Raton. 155–163.
- Boonme P. (2007). Applications of microemulsions in cosmetics. J Cosmet Dermatol, 6:223–228.
- Boonme P, Junyaprasert VB, Suksawad N, Songkro S. (2009). Microemulsions and nanoemulsions: novel vehicles for whitening cosmeceuticals. J Biomed Nanotechnol, 5:373–383.
- Tadros T, Izquierdo P, Esquena J, Solans C. (2004). Formation and stability of nano-emulsions. Adv Colloid Interface Sci, 108-109:303–318.
- Mason TG, Wilking JN, Meleson K, Chang CB, Graves SM. (2006). Nanoemulsions: formation, structure, and physical properties. J Phys Condensed Matt, 18: 635–666.
- de Campos VE, Ricci-Júnior E, Mansur CR. (2012). Nanoemulsions as delivery systems for lipophilic drugs. J Nanosci Nanotechnol, 12:2881–2890.
- Soppimath KS, Aminabhavi TM, Kulkarni AR, Rudzinski WE. (2001). Biodegradable polymeric nanoparticles as drug delivery devices. J Control Release, 70:1–20.
- Kreilgaard M. (2002). Influence of microemulsions on cutaneous drug delivery. Adv Drug Deliv Rev, 54 Suppl 1:S77–S98.
- Solans C, Izquierdo P, Nolla J, Azemar N, Garcia-Celma MJ. (2005). Nanoemulsions. Current Opinion in Colloid & Interface Science, 10:102–110.
- Wulff-Pérez M, Torcello-Gómes A, Gálvez-Ruíz MJ, Martín-Rodríguez A. (2009). Stability of emulsions for parenteral feeding: Preparation and characterization of o/w nanoemulsions with natural oils and Pluronic f68 as surfactant. Food Hydrocolloids, 23:1096–1102.
- Sun W, Sun D, Wei Y, Liu S, Zhang S. (2007). Oil-in-water emulsions stabilized by hydrophobically modified hydroxyethyl cellulose: adsorption and thickening effect. J Colloid Interface Sci, 311:228–236.
- Usón M, Garcia MJ, Solans C. (2004). Formation of water-in-oil (W/O) nano-emulsions in a water/mixed non-ionic surfactant/oil systems prepared by a low-energy emulsification method. Colloids and Surfaces A: Physicochem. Eng. Aspects, Barcelona, 250:415–421.
- Porras M, Solans C, Gonzalez C, Martínez A, Guinart A, Gutierrez JM. (2005). Studies of formation of w/o nano-emulsions. Colloids and Surfaces A: Physicochem. Eng. Aspects, 249:115–118.
- Grams YY, Alaruikka S, Lashley L, Caussin J, Whitehead L, Bouwstra JA. (2003). Permeant lipophilicity and vehicle composition influence accumulation of dyes in hair follicles of human skin. Eur J Pharm Sci, 18:329–336.
- Vyas TK, Shahiwala A, Amiji MM. (2008). Improved oral bioavailability and brain transport of Saquinavir upon administration in novel nanoemulsion formulations. Int J Pharm, 347:93–101.
- Shafiq S, Shakeel F, Talegaonkar S, Ahmad FJ, Khar RK, Ali M. (2007). Development and bioavailability assessment of ramipril nanoemulsion formulation. Eur J Pharm Biopharm, 66:227–243.
- Hatanaka J, Kimura Y, Lai-Fu Z, Onoue S, Yamada S. (2008). Physicochemical and pharmacokinetic characterization of water-soluble Coenzyme Q(10) formulations. Int J Pharm, 363:112–117.
- Kelmann RG, Kuminek G, Teixeira HF, Koester LS. (2007). Carbamazepine parenteral nanoemulsions prepared by spontaneous emulsification process. Int J Pharm, 342:231–239.
- Kotyla T, Kuo F, Moolchandani V, Wilson T, Nicolosi R. (2008). Increased bioavailability of a transdermal application of a nano-sized emulsion preparation. Int J Pharm, 347:144–148.
- Nohynek GJ, Schaefer H. (2001). Benefit and risk of organic ultraviolet filters. Regul Toxicol Pharmacol, 33:285–299.
- Kullavanija P, Lim HW. (2005). Photoprotection. J Am Acad Dermatol, 52:937–958.
- Petrazzuoli M. (2000). Advances in sunscreens. Current Problems in Dermatology, 12:287–290.
- Mansur JS, Breder MNR, Mansur MCA, Azulay RD. (1986). Anais Brasileiros de Dermatologia, 61:167.
- Siewert M, Dressman J, Brown CK, Shah VP; FIP; AAPS. (2003). FIP/AAPS guidelines to dissolution/in vitro release testing of novel/special dosage forms. AAPS PharmSciTech, 4:E7.
- Anvisa (Agência Nacional de Vigilância Sanitária); RE no 899, de 29/05/2003: Guia para validação de métodos analíticos e bioanalíticos, Ministério da Saúde: Brasil, 2003.
- Costa P, Sousa Lobo JM. (2001). Modeling and comparison of dissolution profiles. Eur J Pharm Sci, 13:123–133.
- Mulye NV, Turco SJ. (1995). A simple model based on first order kinetics to explain release of highly water soluble drugs from porous dicalcium phosphate dehydrate. matrices Drug Dev Ind Pharm, 21:943–953.
- Zatz JL. (1995). Drug release from semisolids: effect of membrane permeability on sensitivity to product parameters. Pharm Res, 12:787–789.
- Siewert M, Dressman J, Brown CK, Shah VP; FIP; AAPS. (2003). FIP/AAPS guidelines to dissolution/in vitro release testing of novel/special dosage forms. AAPS PharmSciTech, 4:E7.
- Silva ER, Faria FZM, Brito-Gitirana L, Ricci-Júnior E. (2011). Improving the topical delivery of zinc phthalocyanine using oleic acid as a penetration enhancer: permeation and retention. Drug Dev Ind Pharm, 7:569–575.
- Alvarez-Román R, Barré G, Guy RH, Fessi H. (2001). Biodegradable polymer nanocapsules containing a sunscreen agent: preparation and photoprotection. Eur J Pharm Biopharm, 52:191–195.